Roger G. Pertwee

Aberdeen, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

Journal: British journal of pharmacology

Published: December 29, 2025

A Tourette Syndrome/ADHD-like Phenotype Results from Postnatal Disruption of CB1 and CB2 Receptor Signalling.

A Tourette Syndrome/ADHD-like Phenotype Results from Postnatal Disruption of CB1 and CB2 Receptor Signalling.

Journal: International journal of molecular sciences

Published: April 08, 2025

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.

Journal: British journal of pharmacology

Published: December 20, 2023

The Plant Derived 3-3'-Diindolylmethane (DIM) Behaves as CB2 Receptor Agonist in Prostate Cancer Cellular Models.

The Plant Derived 3-3'-Diindolylmethane (DIM) Behaves as CB2 Receptor Agonist in Prostate Cancer Cellular Models.

Journal: International journal of molecular sciences

Published: November 28, 2022

M3 Receptor Pathway Stimulates Rapid Transcription of the CB1 Receptor Activation through Calcium Signalling and the CNR1 Gene Promoter.

M3 Receptor Pathway Stimulates Rapid Transcription of the CB1 Receptor Activation through Calcium Signalling and the CNR1 Gene Promoter.

Journal: International journal of molecular sciences

Published: October 28, 2022

Displacement Binding Assay Using Human Cannabinoid CB2 Receptor-Transfected Cells.

Displacement Binding Assay Using Human Cannabinoid CB2 Receptor-Transfected Cells.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: September 24, 2022

Cyclic AMP Assay Using Human Cannabinoid CB2 Receptor-Transfected Cells.

Cyclic AMP Assay Using Human Cannabinoid CB2 Receptor-Transfected Cells.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: September 24, 2022

Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands.

Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands.

Journal: Journal of medicinal chemistry

Published: July 18, 2022

Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R).

Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R).

Journal: Frontiers in chemistry

Published: July 01, 2022

Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593.

Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593.

Journal: Frontiers in pharmacology

Published: April 13, 2022

Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells.

Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells.

Journal: Molecules (Basel, Switzerland)

Published: April 05, 2022

Motor-like Tics are Mediated by CB2 Cannabinoid Receptor-dependent and Independent Mechanisms Associated with Age and Sex.

Motor-like Tics are Mediated by CB2 Cannabinoid Receptor-dependent and Independent Mechanisms Associated with Age and Sex.

Journal: Molecular neurobiology

Published: November 19, 2021

Showing 1-12 of 82

Last Updated: 09/26/2026